Evidence map›Paper›PMID 29847474›Full record

ArticleJournal of acquired immune deficiency syndromes (1999)2018

Substantial Heterogeneity in Progress Toward Reaching the 90-90-90 HIV Target in the WHO European Region.

Kholoud Porter, Annabelle Gourlay, Kathy Attawell, David Hales, Virginie Supervie, Giota Touloumi, Magda Rosinska, Georgia Vourli, Ard van Sighem, Anastasia Pharris and 2 more

Abstract read
In one paragraph

Article in Journal of acquired immune deficiency syndromes (1999), 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Human Immunodeficiency Virus Continuum of Care in 11 European Union Countries at the End of 2016 Overall and by Key Population: Have We Made Progress?Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2020
    Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. HIV in Europe and Central Asia: progress in 2018 towards meeting the UNAIDS 90-90-90 targets.Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin · 2018
    Article
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Kholoud PorterInstitute for Global Health, University College London, London, United Kingdom.
Annabelle GourlayInstitute for Global Health, University College London, London, United Kingdom.
Kathy AttawellIndependent Consultant, London, United Kingdom.
David HalesIndependent Consultant, New York, NY.
Virginie SupervieSorbonne Universités, UPMC Univ Paris 06, INSERM, Institut Pierre Louis d'Epidémiologie et de Santé Publique (IPLESP UMRS 1136), Paris, France.
Giota TouloumiMedical School, National and Kapodistrian University of Athens, Athens, Greece.
Magda RosinskaDepartment of Epidemiology, National Institute of Public Health-National Institute of Hygiene, Warsaw, Poland.
Georgia VourliMedical School, National and Kapodistrian University of Athens, Athens, Greece.
Ard van SighemStichting HIV Monitoring, Amsterdam, Netherlands.
Anastasia PharrisEuropean Centre for Disease Prevention and Control, Solna, Sweden.
Teymur NooriEuropean Centre for Disease Prevention and Control, Solna, Sweden.
ECDC Dublin Declaration Monitoring Network

Funding

Medical Research Council MC_U122886351Medical Research Council MC_UU_12023/15
6 · The paper itself

Abstract

backgroundAchieving the UNAIDS 90-90-90 target by 2020 is expected to end the HIV epidemic by 2030. We report on progress in the WHO European Region in meeting this target.

methodsThe European Centre for Disease Prevention and Control (ECDC) sent questionnaires to 55 countries in 2016. We report estimates for 4 stages of the continuum of HIV care (living with HIV, diagnosed, treated, and virally suppressed), corresponding to the Joint United Nations Programme on HIV and AIDS (UNAIDS) target and explore differences by subregion and challenges with reporting data.

findingsForty-four countries provided data for ≥1 stage, and 29 for all 4 stages. Estimated HIV prevalence was 0.19% (range 0.02%-0.84%, n = 37 countries providing stage 1 data). The proportion diagnosed of people living with HIV ranged from 38% to 98% (n = 37 reporting number of people living with HIV and diagnosed). The proportion on ART of those diagnosed ranged from 27% to 96% (n = 40 reporting numbers diagnosed and treated), and viral suppression rates ranged from 32% to 97% (n = 31 providing numbers treated and virally suppressed). The overall continuum of care estimate for 29 countries with complete data was 81-84-88, which differed by subregion: 84-88-90, 84-69-62, and 57-45-57 for the western, central, and eastern subregions, respectively. Challenges in reporting data included absence of a single data source for all stages, shortage of expertise, and lack of financial and human resources.

conclusionsThere is an urgent need to strengthen HIV testing programs throughout Europe, particularly in the eastern subregion, and to remove constraints hampering access to testing and care. Recent changes to treatment guidelines should help reduce the numbers diagnosed not treated.

Indexed as

Anti-HIV AgentsEuropeHIV InfectionsHumansSurveys and QuestionnairesWorld Health OrganizationAnti-HIV Agents

Identifiers

PMID29847474
PMCPMC6104723

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.